Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

Bousquet, 2008, Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen), Allergy, 63, 8, 10.1111/j.1398-9995.2007.01620.x Asher, 2006, Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys, Lancet, 368, 733, 10.1016/S0140-6736(06)69283-0 Katelaris, 2012, Prevalence and diversity of allergic rhinitis in regions of the world beyond Europe and North America, Clin Exp Allergy, 42, 186, 10.1111/j.1365-2222.2011.03891.x Leynaert, 1999, Perennial rhinitis: an independent risk factor for asthma in nonatopic subjects: results from the European Community Respiratory Health Survey, J Allergy Clin Immunol, 104, 301, 10.1016/S0091-6749(99)70370-2 Gergen, 1992, The association of individual allergen reactivity with respiratory disease in a national sample: data from the second National Health and Nutrition Examination Survey, 1976-80 (NHANES II), J Allergy Clin Immunol, 90, 579, 10.1016/0091-6749(92)90130-T Sibbald, 1991, Epidemiology of seasonal and perennial rhinitis: clinical presentation and medical history, Thorax, 46, 895, 10.1136/thx.46.12.895 Pedersen, 1983, Asthma and allergic rhinitis in the same patients, Allergy, 38, 25, 10.1111/j.1398-9995.1983.tb00852.x Greisner, 1998, Co-existence of asthma and allergic rhinitis: a 23-year follow-up study of college students, Allergy Asthma Proc, 19, 185, 10.2500/108854198778557836 Guerra, 2005, Rhinitis is an independent risk factor for developing cough apart from colds among adults, Allergy, 60, 343, 10.1111/j.1398-9995.2005.00717.x Corren, 1992, Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma, J Allergy Clin Immunol, 90, 250, 10.1016/0091-6749(92)90079-H Taramarcaz, 2003, Intranasal corticosteroids for asthma control in people with coexisting asthma and rhinitis, Cochrane Database Syst Rev, CD003570 Zuberbier, 2014, Economic burden of inadequate management of allergic diseases in the European Union: a GA(2) LEN review, Allergy, 69, 1275, 10.1111/all.12470 Haahtela, 2015, Finnish nationwide allergy programme at mid-term—change of direction producing results, Finnish Med J, 70, 2165 Thanaviratananich, 2016, Burden of respiratory disease in Thailand: results from the APBORD observational study, Medicine (Baltimore), 95, e4090, 10.1097/MD.0000000000004090 Yoo, 2016, Burden of respiratory disease in Korea: an observational study on allergic rhinitis, asthma, COPD, and rhinosinusitis, Allergy Asthma Immunol Res, 8, 527, 10.4168/aair.2016.8.6.527 Padjas, 2014, Methodological rigor and reporting of clinical practice guidelines in patients with allergic rhinitis: QuGAR study, J Allergy Clin Immunol, 133, 777, 10.1016/j.jaci.2013.08.029 Bousquet, 2003, Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial, Allergy, 58, 733, 10.1034/j.1398-9995.2003.00076.x Bousquet, 2001, Allergic rhinitis and its impact on asthma, J Allergy Clin Immunol, 108, S147, 10.1067/mai.2001.118891 Guyatt, 2011, GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables, J Clin Epidemiol, 64, 383, 10.1016/j.jclinepi.2010.04.026 Brożek, 2010, Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision, J Allergy Clin Immunol, 126, 466, 10.1016/j.jaci.2010.06.047 Seidman, 2015, Clinical practice guideline: allergic rhinitis, Otolaryngol Head Neck Surg, 152, S1, 10.1177/0194599814561600 Dykewicz, 2003, 7. Rhinitis and sinusitis, J Allergy Clin Immunol, 111, S520, 10.1067/mai.2003.82 van Cauwenberge, 2000, Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology, Allergy, 55, 116, 10.1034/j.1398-9995.2000.00526.x Guyatt, 2011, GRADE guidelines: 2. Framing the question and deciding on important outcomes, J Clin Epidemiol, 64, 395, 10.1016/j.jclinepi.2010.09.012 2014 Deeks JJ, Higgins JPT, Altman DG, on behalf of the Cochrane Statistical Methods Group. The standardized mean difference. In: Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions version 5.0.1 [updated September 2008]. Available at: http://www.cochrane-handbook.org/. Cohen, 1988 Higgins, 2011, The Cochrane Collaboration's tool for assessing risk of bias in randomised trials, BMJ, 343, d5928, 10.1136/bmj.d5928 Balshem, 2011, GRADE guidelines: 3. Rating the quality of evidence, J Clin Epidemiol, 64, 401, 10.1016/j.jclinepi.2010.07.015 Schunemann, 2016, Development of the GRADE Evidence to Decision (EtD) frameworks for tests in clinical practice and public health, J Clin Epidemiol, 76, 89, 10.1016/j.jclinepi.2016.01.032 Bousquet, 2016, AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation, Eur Respir J, 47, 1028, 10.1183/13993003.01856-2015 Bousquet, 2014, Integrated care pathways for airway diseases (AIRWAYS-ICPs), Eur Respir J, 44, 304, 10.1183/09031936.00014614 Bousquet, 2015, Portugal at the cross road of international chronic respiratory programmes, Rev Port Pneumol (2006), 21, 230 Costa, 2011, How representative are clinical study patients with allergic rhinitis in primary care?, J Allergy Clin Immunol, 127, 920, 10.1016/j.jaci.2010.10.058 Bousquet, 2009, Unmet needs in severe chronic upper airway disease (SCUAD), J Allergy Clin Immunol, 124, 428, 10.1016/j.jaci.2009.06.027 Alonso-Coello, 2016, GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 2: Clinical practice guidelines, BMJ, 353, i2089, 10.1136/bmj.i2089 Alonso-Coello, 2016, GRADE evidence to decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction, BMJ, 353, i2016, 10.1136/bmj.i2016 Neumann, 2016, The GRADE evidence-to-decision framework: a report of its testing and application in 15 international guideline panels, Implement Sci, 11, 93, 10.1186/s13012-016-0462-y Schunemann, 2011, Guidelines 2.0: do no net harm-the future of practice guideline development in asthma and other diseases, Curr Allergy Asthma Rep, 11, 261, 10.1007/s11882-011-0185-8 Bousquet, 2016, Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5), Clin Transl Allergy, 6, 29, 10.1186/s13601-016-0116-9 Bousquet, 2016, MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis, J Allergy Clin Immunol, 138, 367, 10.1016/j.jaci.2016.03.025 Bourret, 2015, MASK-rhinitis, a single tool for integrated care pathways in allergic rhinitis, World Hosp Health Serv, 51, 36 Bousquet, 2015, MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): the new generation guideline implementation, Allergy, 70, 1372, 10.1111/all.12686